Latest News

January 2021

The UK rollout plan for the Oxford/AstraZeneca vaccine has been changed, but Pfizer/BioNTech say their vaccine was not designed to be used in two shots 12 weeks apart:


Three more coronavirus vaccines are expected early this year, from Novavax, AstraZeneca and Johnson & Johnson:


A novel computational drug screening strategy developed in China has determined that pralatrexate outperforms remdesivir in inhibiting the Covid-19 virus:


The pharmaceutical industry sifts through the details of the EU trade deal:


What the UK-EU Trade and Cooperation Agreement means for pharma and medical device companies:


According to the report “Contract Research Organization (CRO) Market” the global contract research organisation market size is expected to surge at 11.48% CAGR through to 2023:


The Europe contract research organization (CRO) market is expected to grow with a CAGR of 7.7% from 2018-2025:


Moderna has announced the Phase 3 study of its COVID-19 vaccine candidate, mRNA-1273, has demonstrated efficacy of 94.5%:


Sunderland-based CRO Onyx Scientific has announced a multi-million pound investment in its facility which will be used for non-GMP & GMP Phase I – III and commercial API manufacturing:


The Medicines and Healthcare products Regulatory Agency (MHRA) has published a guidance document for clinical trial sponsors and research organisations dealing with the submission of Suspected Unexpected Serious Adverse Drug Reactions and Development Safety Update Reports following the end of the Brexit transition period (requires free trial registration):


Oracle Partner NCC Group

Customer Area